Total planned funding: $220,638,575
Allocations
Countries/Regions
Eswatini | $220,638,575 |
Organizational Types
Private Contractor | $65,888,159 |
University | $44,903,129 |
NGO | $35,548,877 |
Own Agency | $28,683,036 |
Unknown | $24,943,828 |
Host Country Government Agency | $7,196,514 |
FBO | $6,984,196 |
Multi-lateral Agency | $5,678,202 |
Other USG Agency | $812,634 |
Implementing Agency | $0 |
Program Areas
Care | $72,285,595 |
Treatment | $54,785,426 |
Prevention | $36,269,195 |
Governance and Systems | $22,292,862 |
Testing | $19,667,842 |
Management and Operations | $15,337,655 |
Budget Codes
HTXS: Treatment: Adult Treatment | $41,578,025 |
HBHC: Care: Adult Care and Support | $33,561,006 |
HKID: Care: Orphans and Vulnerable Children | $21,728,053 |
HVCT: Testing: HIV Testing and Counseling | $19,667,842 |
HVMS: Management and Operations | $15,337,655 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,291,730 |
HVTB: Care: TB/HIV | $12,111,916 |
OHSS: Health Systems Strengthening | $10,112,410 |
HVOP: Sexual Prevention: Other Sexual Prevention | $9,436,504 |
HTXD: Treatment: ARV Drugs | $9,251,636 |
HVSI: Strategic Information | $8,812,796 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,797,947 |
PDCS: Care: Pediatric Care and Support | $4,884,620 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,219,228 |
PDTX: Treatment: Pediatric Treatment | $3,955,765 |
HLAB: Laboratory Infrastructure | $3,367,656 |
HMBL: Biomedical Prevention: Blood Safety | $523,786 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$36,363,700
Countries/Regions
Pact, Inc.:
$25,953,123
Countries/Regions
Not Available:
$20,544,842
Countries/Regions
USG Aggregated Agencies:
$15,472,284
Countries/Regions